NCT05636878

Brief Summary

The research system is a Mobile Perinatal Psychiatry Team (EMPPer), for children aged 0 to 3 and their parents. it facilitates access to psychiatric care by going to families who need it and who are in difficulty to ensure this process. This device, already deployed in a dozen French cities for several years, convinced the teams of its interest, without demonstrating its effectiveness by evaluation conducted according to research standards. The deployment of a Mobile Perinatal Psychiatry Team in a region not yet equipped (Meurthe-et-Moselle Sud) would therefore offer the opportunity to assess its effectiveness, The main objective of the research is to evaluate the effect of the EMPPer on the prevalence of abnormalities in the psychomotor development of children at the age of 2 years, in comparison with similar territories that do not benefit from it, and in comparison with the period preceding the establishment of the EMPPer in the targeted territory.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,260

participants targeted

Target at P75+ for not_applicable

Timeline
28mo left

Started Aug 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Aug 2023Aug 2028

First Submitted

Initial submission to the registry

September 14, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 5, 2022

Completed
9 months until next milestone

Study Start

First participant enrolled

August 18, 2023

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 18, 2028

Last Updated

February 8, 2024

Status Verified

December 1, 2023

Enrollment Period

4.3 years

First QC Date

September 14, 2022

Last Update Submit

February 7, 2024

Conditions

Keywords

PerinatalPsychiatrypsychomoteurchildren

Outcome Measures

Primary Outcomes (1)

  • Number of participants with anomaly of the child's psychomotor development at age 2 years

    It defined by the fact of having at least one box ticked "no" in the psychomotor development section of the medical part of the third health certificate , carried out after a systematic examination at the age of 24 months of the child

    up to 24 months

Secondary Outcomes (4)

  • Number of Children with Language Delay at age 4

    up to 4 years

  • Therapeutic alliance score

    up to 4 years

  • User satisfaction score

    up to 4 years

  • the cost of care for children with a psychomotor development problem

    2 years

Study Arms (2)

With EMPPer

EXPERIMENTAL

All children (0 to 3 years old) in the areas Meurthe-et-Moselle South will benefit from the intervention of the Mobile Perinatal Psychiatry Team (EMPPer)

Other: Mobile Intervention Team in Perinatal Psychiatry (EMPPer)

without EMPPer

NO INTERVENTION

All children (0 to 3 years) from Strasbourg and Reims will not benefit from the Mobile Intervention Team in Perinatal Psychiatry

Interventions

The Mobile Intervention Team in Perinatal Psychiatry consists in going towards the most excluded patients, changing the organization of care compared to the current practice and facilitating access to care for the most vulnerable populations

With EMPPer

Eligibility Criteria

Age1 Day - 3 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children benefiting from EMPPer intervention
  • Children affiliated or entitled to a social security system
  • Children for whom the holder of parental authority has received informed information about the study and has co-signed, with the investigator, a consent to participate in the study

You may not qualify if:

  • Children whose parents are visiting the region ( vacations, family visits ...)
  • Children for whom the 2 holders of parental authority do not speak french
  • Children for whom both parents do not know how to read

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Psychothérapique de Nancy

Laxou, France

RECRUITING

Related Publications (4)

  • Antenatal and postnatal mental health: clinical management and service guidance. London: National Institute for Health and Care Excellence (NICE); 2018 Apr. Available from http://www.ncbi.nlm.nih.gov/books/NBK553127/

    PMID: 31990493BACKGROUND
  • Alla F, Guillemin F, Colombo MC, Roy B, Maeder C. [Diagnostic value of ERTL4: a screening test of language disorders in 4-year-old children]. Arch Pediatr. 1998 Oct;5(10):1082-8. doi: 10.1016/s0929-693x(99)80004-9. French.

    PMID: 9809150BACKGROUND
  • Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M; Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008 Sep 29;337:a1655. doi: 10.1136/bmj.a1655.

    PMID: 18824488BACKGROUND
  • Dupont C, Touzet S, Ploin D, Croidieu C, Balsan M, Mazas AS, Rudigoz RC. [Evaluation of the perinatal network professionals' integration: study about 653 professionals of AURORE network]. J Gynecol Obstet Biol Reprod (Paris). 2007 Jun;36(4):375-83. doi: 10.1016/j.jgyn.2007.01.003. Epub 2007 Feb 20. French.

    PMID: 17317036BACKGROUND

MeSH Terms

Conditions

Congenital Abnormalities

Condition Hierarchy (Ancestors)

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Fabienne LIGIER, Pr.

    Centre Psychothérapique de Nancy

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Naoual MELLOUKI BENDIM'RED, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: For the primary objective, i.e., analysis of the effect of the intervention at age 2 (and the first SO, i.e., analysis of the effect of the intervention at age 4), a difference-in-differences analysis will be performed. That is, the difference in the prevalence of abnormal psychomotor development at age 2 (and at age 4) before and after the implementation of the EMPPer in the target territory will be compared to the difference in the prevalence of abnormal psychomotor development at age 2 (and at age 4) between the periods corresponding to the implementation of the EMPPer in the territories that did not benefit from it, using a mixed linear regression model with psychomotor developmental abnormalities as the variable to be explained, year (pre vs. post intervention) and region (with vs. without intervention) as explanatory variables, and which will include the year\*region interaction. The assumption of equivalence of temporal developmental trends here and elsewhere will be tested
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 14, 2022

First Posted

December 5, 2022

Study Start

August 18, 2023

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

August 18, 2028

Last Updated

February 8, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations